Drugs / Liposome encapsulated BoNT-A
Liposome encapsulated BoNT-A
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02247557 | Sep 2014 → Feb 2017 | interstitial cystitis | Buddhist Tzu Chi General Hospital | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Liposome encapsulated BoNT-A | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02247557 ↗ |
| Known as | BoNT-A | “Liposome encapsulated BoNT-A ( mixed BOTOX 200U/10ml in Liposome 80mg/40ml) in single intravesical instillation” NCT02247557 ↗ |
| Known as | BOTOX | “Liposome encapsulated BoNT-A ( mixed BOTOX 200U/10ml in Liposome 80mg/40ml) in single intravesical instillation” NCT02247557 ↗ |
| Modality | Protein / enzyme biologic | “botulinum toxin protein across the cell membrane” NCT02247557 ↗ |
| Route | Other | “intravesical instillation” NCT02247557 ↗ |